Simultaneous determination of aneuploidy and fetal fraction
US11952623B2 · kind B2 · utility
0Cited by
13References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2021 |
| Grant date | Apr 9, 2024 |
| Priority date | — |
| Expiry date | Feb 9, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/112
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for simultaneously determining the presence or absence of fetal aneuploidy and the relative amount of fetal nucleic acids in a sample obtained from a pregnant female. The method encompasses the use of sequencing technologies and exploits the occurrence of polymorphisms to provide a streamlined noninvasive process applicable to the practice of prenatal diagnostics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.